How have RGT shares performed this year?

Argent BioPharma's stock was trading at GBX 16.15 at the beginning of the year. Since then, RGT shares have increased by 4.5% and is now trading at GBX 16.88. View the best growth stocks for 2024 here .

How do I buy shares of Argent BioPharma?

Shares of RGT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:RGT

Argent BioPharma (RGT) Share Price, News & Analysis

GBX 16.88

+0.66 (+4.07%)

(As of 09:49 AM ET)

Compare

Today's Range: 16.75
▼
17.40
50-Day Range: N/A
52-Week Range: 10
▼
24

Volume: 1,202 shs
Average Volume: 6,302 shs
Market Capitalization: £8.17 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors

Get Argent BioPharma alerts:

Ad Porter & Company

War on Elon Escalates…

Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

Click here to learn how you can benefit from its widespread distribution.

About Argent BioPharma

Argent BioPharma Limited, a drug discovery clinical-stage biopharmaceutical company, provides medicines targeting immunology and neurology worldwide. Its principal product candidates include CimetrA, which is in phase II clinical trial for the treatment of SLE Lupus, anti-inflammatory, and SARS COVID-19; and CannEpil, which is in phase I clinical trial for refractory epilepsy and cerebral palsy; and CogniCann, which is in phase I clinical trial for the symptomatic relief of Dementia and Alzheimer. In addition, the company provides Irnican for brain cancer. The company was formerly known as MGC Pharmaceuticals Limited and changed it name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.

RGT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RGT Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive RGT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Argent BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: LON:RGT
CUSIP: N/A
CIK: N/A
Web: argentbiopharma.com
Phone: 61-8-6555-2950
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.24)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-17,530,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -108.57%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.22
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: GBX (11) per share
Price / Book: -1.53

Miscellaneous

Outstanding Shares: 48,410,000
Free Float: N/A
Market Cap: £8.17 million
Optionable: N/A
Beta: 1.05

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Roby Reuven Zomer (Age 44)
Co-Founder, CEO, MD & Executive Director
Comp: $181.27k
Mr. Igor Bluvstein (Age 42)
Chief Financial Officer
Ms. Yifat Steuer
Deputy CEO & COO
Mr. Tom Cairns
Chief Accounting Officer
Ms. Nicole Ann Godresse
Global Chief Sales Officer
Mr. Amir Polak
Chief Pharmaceutical Development Officer
Ms. Sabina Suljakovic
Head of the Quality Assurance Department
Dr. Nadya Lisovoder
Chief Medical Officer
Ms. Sasha Friedman
Deputy CEO
Yair Tal
Chief Information Security Officer

Key Competitors

View All Competitors

RGT Stock Analysis - Frequently Asked Questions

How have RGT shares performed this year?: Argent BioPharma's stock was trading at GBX 16.15 at the beginning of the year. Since then, RGT shares have increased by 4.5% and is now trading at GBX 16.88.
View the best growth stocks for 2024 here.
How do I buy shares of Argent BioPharma?: Shares of RGT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.